Pacific Point Advisors LLC Purchases 3,000 Shares of Astera Labs, Inc. $ALAB

Key Points

• Pacific Point Advisors LLC increased its stake in Astera Labs by 42.9%, acquiring an additional 3,000 shares to reach a total of 10,000 shares valued at approximately $904,000.
• Institutional investors now own 60.47% of Astera Labs, with recent significant purchases made by various firms collectively investing over $1 million during the second quarter.
• Astera Labs reported a 149.5% year-over-year revenue increase for the quarter, with earnings per share of $0.44, exceeding analysts' expectations of $0.33.

Pacific Point Advisors LLC grew its position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 42.9% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 10,000 shares of the company's stock after buying an additional 3,000 shares during the quarter. Pacific Point Advisors LLC's holdings in Astera Labs were worth $904,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. PFG Investments LLC bought a new position in Astera Labs in the 2nd quarter valued at approximately $238,000. Janney Montgomery Scott LLC bought a new stake in shares of Astera Labs in the 2nd quarter worth $559,000. GC Wealth Management RIA LLC purchased a new position in shares of Astera Labs in the second quarter worth $318,000. Sound Income Strategies LLC raised its stake in shares of Astera Labs by 31.1% in the second quarter. Sound Income Strategies LLC now owns 1,038 shares of the company's stock worth $94,000 after purchasing an additional 246 shares during the last quarter. Finally, Clay Northam Wealth Management LLC bought a new position in shares of Astera Labs during the second quarter valued at $235,000. Institutional investors own 60.47% of the company's stock.

Insider Buying and Selling

In other news, COO Sanjay Gajendra sold 280,000 shares of the firm's stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $170.02, for a total value of $47,605,600.00. Following the transaction, the chief operating officer owned 5,525,545 shares of the company's stock, valued at $939,453,160.90. This trade represents a 4.82% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Michael Truett Tate sold 100,000 shares of Astera Labs stock in a transaction dated Thursday, August 7th. The shares were sold at an average price of $171.38, for a total value of $17,138,000.00. Following the transaction, the chief financial officer directly owned 518,996 shares in the company, valued at approximately $88,945,534.48. The trade was a 16.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,513,027 shares of company stock valued at $233,510,161 in the last 90 days. 12.50% of the stock is owned by company insiders.

Analyst Ratings Changes

ALAB has been the subject of several research analyst reports. Zacks Research upgraded Astera Labs to a "strong-buy" rating in a report on Tuesday, August 12th. Wall Street Zen upgraded shares of Astera Labs from a "hold" rating to a "buy" rating in a research note on Saturday, August 16th. Northland Capmk cut shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a report on Tuesday, July 22nd. Needham & Company LLC increased their price objective on shares of Astera Labs from $100.00 to $170.00 and gave the company a "buy" rating in a research report on Wednesday, August 6th. Finally, Jefferies Financial Group lifted their target price on shares of Astera Labs from $95.00 to $130.00 and gave the stock a "buy" rating in a research report on Tuesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $152.94.

Astera Labs Stock Down 1.5%

Shares of NASDAQ:ALAB opened at $195.80 on Wednesday. The stock has a market capitalization of $32.55 billion, a PE ratio of 349.64, a price-to-earnings-growth ratio of 5.04 and a beta of 1.48. The firm's 50 day moving average price is $185.00 and its 200-day moving average price is $116.75. Astera Labs, Inc. has a twelve month low of $47.13 and a twelve month high of $262.90.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. The business had revenue of $191.93 million during the quarter, compared to analysts' expectations of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The firm's revenue was up 149.5% on a year-over-year basis. During the same period in the prior year, the company earned $0.13 earnings per share. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.